American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors

医学 老年学 癌症 人口 生活质量(医疗保健) 不利影响 癌症幸存者 替代医学 癌症预防 运动医学 疾病 物理疗法 家庭医学 内科学 护理部 病理 环境卫生
作者
Kathryn H. Schmitz,Kerry S. Courneya,Charles E. Matthews,Wendy Demark‐Wahnefried,Daniel A. Galvão,Bernardine M. Pinto,Melinda L. Irwin,Kathleen Y. Wolin,Roanne Segal,Alejandro Lucía,Carole M. Schneider,Vivian E. von Gruenigen,Anna L. Schwartz
出处
期刊:Medicine and Science in Sports and Exercise [Ovid Technologies (Wolters Kluwer)]
卷期号:42 (7): 1409-1426 被引量:2689
标识
DOI:10.1249/mss.0b013e3181e0c112
摘要

Early detection and improved treatments for cancer have resulted in roughly 12 million survivors alive in the United States today. This growing population faces unique challenges from their disease and treatments, including risk for recurrent cancer, other chronic diseases, and persistent adverse effects on physical functioning and quality of life. Historically, clinicians advised cancer patients to rest and to avoid activity; however, emerging research on exercise has challenged this recommendation. To this end, a roundtable was convened by American College of Sports Medicine to distill the literature on the safety and efficacy of exercise training during and after adjuvant cancer therapy and to provide guidelines. The roundtable concluded that exercise training is safe during and after cancer treatments and results in improvements in physical functioning, quality of life, and cancer-related fatigue in several cancer survivor groups. Implications for disease outcomes and survival are still unknown. Nevertheless, the benefits to physical functioning and quality of life are sufficient for the recommendation that cancer survivors follow the 2008 Physical Activity Guidelines for Americans, with specific exercise programming adaptations based on disease and treatment-related adverse effects. The advice to "avoid inactivity," even in cancer patients with existing disease or undergoing difficult treatments, is likely helpful.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Owen应助明理怜珊采纳,获得10
刚刚
tjxx发布了新的文献求助10
刚刚
2秒前
2秒前
2秒前
3秒前
简单花花发布了新的文献求助10
4秒前
Hello应助科研通管家采纳,获得10
5秒前
浮游应助科研通管家采纳,获得10
5秒前
顺颂时祺完成签到,获得积分20
5秒前
浮游应助科研通管家采纳,获得10
5秒前
小蘑菇应助科研通管家采纳,获得10
5秒前
科研通AI6应助科研通管家采纳,获得10
5秒前
CodeCraft应助科研通管家采纳,获得10
5秒前
Lucas应助科研通管家采纳,获得30
5秒前
Jasper应助科研通管家采纳,获得10
5秒前
在水一方应助科研通管家采纳,获得10
6秒前
我是老大应助科研通管家采纳,获得10
6秒前
思源应助灵巧的傲柏采纳,获得10
6秒前
Jasper应助科研通管家采纳,获得10
6秒前
思源应助科研通管家采纳,获得10
6秒前
浮游应助科研通管家采纳,获得10
6秒前
FashionBoy应助科研通管家采纳,获得10
6秒前
林诗茜完成签到,获得积分20
6秒前
老福贵儿应助科研通管家采纳,获得10
6秒前
Hello应助科研通管家采纳,获得30
6秒前
爆米花应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得10
6秒前
bkagyin应助科研通管家采纳,获得10
6秒前
无花果应助科研通管家采纳,获得10
6秒前
Akim应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得10
6秒前
浮游应助科研通管家采纳,获得10
6秒前
CipherSage应助科研通管家采纳,获得10
6秒前
orixero应助科研通管家采纳,获得10
6秒前
gengen应助科研通管家采纳,获得10
7秒前
在水一方应助科研通管家采纳,获得10
7秒前
Zx_1993应助科研通管家采纳,获得100
7秒前
小二郎应助科研通管家采纳,获得10
7秒前
7秒前
高分求助中
Aerospace Standards Index - 2025 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Treatise on Geochemistry (Third edition) 1600
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
List of 1,091 Public Pension Profiles by Region 981
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5456885
求助须知:如何正确求助?哪些是违规求助? 4563403
关于积分的说明 14289910
捐赠科研通 4488050
什么是DOI,文献DOI怎么找? 2458202
邀请新用户注册赠送积分活动 1448478
关于科研通互助平台的介绍 1424132